Gantenerumab
From Self-sufficiency
| Monoclonal antibody | |
|---|---|
| Type | Whole antibody |
| Source | Template:Infobox drug/mab source |
| Target | Beta-amyloid (Aβ40/42) |
| Identifiers | |
| CAS Number | 89957-37-9 |
| ATC code | none |
| Chemical data | |
| Formula | C6496H10072N1740O2024S42 |
| Molar mass | 146.3 kDa (peptide)[[Script error: No such module "String".]] |
Gantenerumab is a monoclonal antibody for the treatment of Alzheimer's disease.[1][2] A phase I clinical trial has been conducted in 2006/07.[3]
References
- ↑ Statement On A Nonproprietary Name Adopted By The Usan Council - Gantenerumab American Medical Association.
- ↑ International Nonproprietary Names for Pharmaceutical Substances (INN), World Health Organization.
- ↑ ClinicalTrials.gov NCT00531804 A Multiple Ascending Dose Study of R1450 in Patients With Alzheimer Disease
| 40x30px | This monoclonal antibody-related article is a stub. You can help ssf by expanding it. |
| 40px | This antineoplastic or immunomodulatory drug article is a stub. You can help ssf by expanding it. |
Categories:
- Pages with script errors
- Drugs that are a monoclonal antibody
- Infobox drug tracked parameters
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs not assigned an ATC code
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- 2Fix
- Pages with broken file links
- Monoclonal antibody stubs
- Antineoplastic and immunomodulating drug stubs
